Atlas Trials

Somatostatin Receptors Imaging in Relapsing and Refractory Multiple Myeloma Patients

Clinical trial NCT04379817 · COMPLETED

Trial details

NCT number
NCT04379817
Sponsor
Jules Bordet Institute
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2020-02-25
Primary completion
2024-05-23
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.